Porcine model of diabetic dyslipidemia: Insulin and feed algorithms for mimicking diabetes mellitus in humans

Comparative Medicine

Volumn 53, Issue 1, 2003, Pages 42-52

  Boullion, Robert D ^a   Mokelke, Eric A ^a   Wamhoff, Brian R ^a   Otis, Christine R ^a   Wenzel, James ^a   Dixon, Joseph L ^a,b   Sturek, Michael ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ALGORITHM; ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ENERGY BALANCE; EXERCISE; HEART; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; JOB PERFORMANCE; LIPID METABOLISM; LOW FAT DIET; MALE; NEPHROTOXICITY; NONHUMAN; PHYSIOLOGY; SITTING; STARVATION; SWINE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ALGORITHMS; ANIMAL FEED; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; HUMANS; HYPERLIPIDEMIAS; INSULIN; MALE; PHYSICAL CONDITIONING, ANIMAL; SWINE;

EID: 0037296144     PISSN: 00236764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Tesfamariam, B., J. Palacino, R. Weisbrod, and R. Cohen. 1993. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J. Cardiovasc. Pharmacol. 21:205- 211.
2. +, ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. J. Clin. Invest. 90:727-732.
3. + pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibition. Am. J. Physiol. Heart Circ. Physiol. 265:H1189-H1194.
4. 2. Am. J. Physiol. 257:H1327-H1333.
5. Capron, L., J. Jarnet, S. Kazandjian, and E. Housset. 1986. Growth-promoting effects of diabetes and insulin on arteries - an in vivo study of rat aorta. Diabetes 35:973-978.
6. Hoang, K., I. Chen, G. Reaven, L. Zhang, H. Ross, M. Billingham, and H. Valantine. 1998. Diabetes and dyslipidemia - a new model for transplant coronary artery disease. Circulation 97:2160-2168.
7. Pijl, A., A. Van der Wal, M.-J. Mathy, K. Kam, M. Hendriks, M. Pfaffendorf, and P. Van Zwieten. 1994. Streptozotocin-induced diabetes mellitus in spontaneously hypertensive rats: a pathophysiological model for the combined effects of hypertension and diabetes. J. Pharmacol. Toxicol. Methods 32:225-233.
8. Litwak, K., W. Cefalu, and J. Wagner. 1998. Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skin glycation, and pancreatic islets. Lab. Anim. Sci. 48:172-178.
9. Zhao, G., X. Zhang, C. Smith, X. Xu, M. Ochoa, D. Greenhouse, T. Vogel, C. Curran, and T. Hintze. 1999. Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes. Am. J. Physiol. Heart Circ. Physiol. 277:H268-H278.
10. O'Hea, E., G. Allee, G. Leveille, and D. Baker. 1971. Observations on the alloxan-diabetic pig. Int. J. Biochem. 2:177-181.
11. Suzuki, L., M. Poot, R. Gerrity, and K. Bornfeldt. 2001. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis. (Lack of direct growth-promoting effects of high glucose levels.). Diabetes 50:851-860.
12. Romsos, D., G. Leveille, and G. Allee. 1971. Alloxan diabetes in the pig (Sus domesticus). Response to glucose, tolbutamide and insulin administration. Comp. Biochem. Physiol. 40A:557-568.
13. Chaturvedi, N., L. Stevens, J. Fuller, and The WHO Multinational Study Group. 1995. Mortality and morbidity associated with body weight in people with IDDM: the WHO multinational study of vascular disease in diabetes. Diabetes Care 18:761- 765.
14. Phillips, R., L. Panepinto, and D. Will. 1979. Genetic selection for diabetogenic traits in Yucatan miniature swine. Diabetes 28:1102-1107.
15. Phillips, R. and L. Panepinto. 1986. Swine as a model for human diabetes, p.549-560. In M. Tumbleson (ed.), Swine in biomedical research. Plenum Press, New York.
16. Jokinen, M., T. Clarkson, and R. Prichard. 1985. Animal models in atherosclerosis research. Exp. Mol. Pathol. 42:1-28.
17. Douglas, W. 1972. Of pigs and men and research: A review of applications and analogies of the pig, Sus scrofa, in human medical research. (Review). Space Life Sci. 3:226-234.
18. Lee, K. 1986. Swine as animal models in cardiovascular research, p. 1481-1496. In M. Tumbleson (ed.), Swine in biomedical research. Plenum Press, New York.
19. Phillips, R., L. Panepinto, R. Spangler, and N. Westmoreland. 1982. Yucatan miniature swine as a model for the study of human diabetes -mellitus. Diabetes 31:30-36.
20. White, F. and C. Bloor. 1986. The pig as a model for myocardial ischemia, p. 481-490. In M. Tumbleson (ed.), Swine in biomedical research. Plenum Press, New York.
21. Schaper, W. and J. Schaper. 1993. Collateral circulation, p. 1- 406. Kluwer, New York.
22. Dixon, J., J. Stoops, J. Parker, M. Laughlin, G. Weisman, and M. Sturek. 1999. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler. Thromb. Vasc. Biol. 19:2981-2992.
23. 2+ signaling associated with diabetic dyslipidemia. J. Vasc. Res. 39:208-220.
24. Dixon, J., S. Shen, J. Vuchetich, E. Wysocka, G. Sun, and M. Sturek. 2002. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J. Lipid Res. 43:1618-1629.
25. Gerrity, R., R. Natarajan, J. Nadler, and T. Kimsey. 2001. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 50:1654-1665.
26. Natarajan, R., R. Gerrity, J. Gu, L. Lanting, L. Thomas, and J. Nadler. 2002. Role of 12-lipoxygenase and oxidant stress in hyperglycemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 45:125-133.
27. Mahley, R., K. Weisgraber, T. Innerarity, H. Brewer Jr., and G. Assmann. 1975. Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry 14:2817-2823.
28. Bell, F. and R. Gerrity. 1992. Evidence for an altered lipid metabolic state in circulating blood monocytes under conditions of hyperlipemia in swine and its implications in arterial lipid metabolism. Arterioscler. Thromb. 12:155-162.
29. Hall, J., W. Stanley, G. Lopaschuk, J. Wisneski, R. Pizzurro, C. Hamilton, and J. McCormack. 1996. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am. J. Physiol. Heart Circ. Physiol. 271:H2320-H2329.
30. Otis, C., B. Wamhoff, and M. Sturek. 2002. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp. Med. 53:53-64.
31. Hainsworth, D., M. Katz, D. Sanders, D. Sanders, E. Wright, and M. Sturek. 2002. Retinal capillary basement membrane thickening in a porcine model of diabetes. Comp. Med. 52:421-427.
32. Panepinto, L., R. Phillips, S. Norden, P. Pryor, and R. Cox. 1983. A comfortable, minimum stress method of restraint for Yucatan miniature swine. Lab. Anim. Sci. 33:95-97.
33. Bailie, M., S. Wixson, and M. Landi. 1986. Vascular-access-port implantation for serial blood sampling in conscious swine. Lab. Anim. Sci. 36:431-433.
34. Rerup, C. 1970. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22:485-517.
35. Lenzen, S. and U. Panten. 1988. Alloxan: history and mechanism of action. Diabetologia 31:337-342.
36. Bloor, C., F. White, and T. Sanders. 1984. Effects of exercise on collateral development in myocardial ischemia in pigs. J. Appl. Physiol. 56:656-665.
37. Hill, B., J. Dixon, and M. Sturek. 2001. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 159:117-124.
38. Hill, B., E. Price, J. Dixon, and M. Sturek. 2002. Increased calcium buffering in coronary smooth muscle cells from diabetic dyslipidemic pigs. Atherosclerosis, in press.
39. Sturek, M., C. Otis, B. Wamhoff, J. Dixon, J. Turk, and H. Reddy. 2001. Dyslipidemia, not hyperglycemia, is the main factor eliciting coronary artery disease in Yucatan swine. Arterioscler. Thromb. Vasc. Biol. 21:644-644.
40. Phillips, R., N. Westmoreland, L. Panepinto, and G. Case. 1982. Dietary effects on metabolism of Yucatan miniature swine selected for low and high glucose utilization. J. Nutr. 112:104- 111.
41. Wangsness, P., R. Martin, and J. Gahagan. 1977. Insulin and growth hormone in lean and obese pigs. Am. J. Physiol. 233:E104- E108.
42. Martin, R., J. Gobble, T. Hartsock, H. Graves, and J. Ziegler. 1973. Characterization of an obese syndrome in the pig. Proc. Soc. Exp. Biol. Med. 143:198-203.
43. Kelly, C. and I. Fantus. 1995. Insulin binding in non-insulin dependent diabetes mellitus (NIDDM) is correlated with glycemic control: clinical evidence for abnormal receptor regulation in NIDDM. Metabolism 44:506-512.
44. Chaturvedi, N., J. Fuller, and The WHO Multinational Study Group. 1995. Mortality risk by body weight and weight change in people with NIDDM: the WHO multinational study of vascular disease in diabetes. Diabetes Care 18:766-774.
45. Chobanian, A., E. Arquilla, T. Clarkson, H. Eder, C. Howard, Jr., T. Regan, and J. Williamson. 1982. Cardiovascular complications. Diabetes 31:54-64.
46. Barrett-Connor, E. 1997. Does hyperglycemia really cause coronary heart disease? Diabetes Care 20:1620-1623.
47. Semenkovich, C. and J. Heinecke. 1997. The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes 46:327-334.